Published in Thorax on April 01, 1984
Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma. Results in 120 consecutive patients. Ann Surg (1996) 1.35
Angiogenesis is an independent prognostic factor in malignant mesothelioma. Br J Cancer (2001) 0.92
A systematic review of lung-sparing extirpative surgery for pleural mesothelioma. J R Soc Med (2011) 0.87
Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary carcinoma in nude mice. Br J Cancer (1994) 0.87
High-dose methotrexate in the treatment of malignant mesothelioma of the pleura. A phase II study. Br J Cancer (1992) 0.83
Pleural mesothelioma treated by fast neutron therapy. Thorax (1985) 0.81
Malignant mesothelioma. J R Soc Med (1989) 0.79
Malignant pleural mesothelioma in western Glasgow 1980-6. Thorax (1989) 0.79
Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study. Br J Cancer (1995) 0.79
Intrapleural hypotonic cisplatin treatment for malignant pleural mesothelioma: in vitro experiments and clinical application. Surg Today (2006) 0.79
Nanoparticle tumor localization, disruption of autophagosomal trafficking, and prolonged drug delivery improve survival in peritoneal mesothelioma. Biomaterials (2016) 0.76
The evolution of the diminishing role of extrapleural pneumonectomy in the surgical management of malignant pleural mesothelioma. Onco Targets Ther (2016) 0.75
Diffuse malignant pleural mesothelioma and asbestos exposure. Thorax (1971) 3.39
The clinical aspects of mesothelioma. Q J Med (1976) 2.60
Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax (1976) 2.38
Localized mesothelioma of the pleura: benign and malignant variants. J Thorac Cardiovasc Surg (1978) 1.92
Malignant mesothelioma of the pleura: relation between histological type and clinical behaviour. Thorax (1982) 1.76
Diffuse malignant mesothelioma. Prospective evaluation of 69 patients. Ann Intern Med (1982) 1.75
Pleural mesotheliomas. Clinical experiences with thirty-seven patients. Am J Roentgenol Radium Ther Nucl Med (1967) 1.65
Malignant mesothelioma of the pleura: review of 123 patients. Cancer (1982) 1.55
Diffuse malignant pleural mesothelioma in Glasgow. Br J Dis Chest (1981) 1.44
Malignant pleural mesothelioma. Report of 19 cases. J Thorac Cardiovasc Surg (1976) 1.26
Mesothelioma following exposure to asbestos: a review of 72 cases. Chest (1973) 1.24
Diffuse malignant mesothelioma of the pleura: a review of 37 cases. Chest (1971) 1.19
Multimodality therapy for malignant mesothelioma based on a study of natural history. Am J Med (1980) 1.19
Radiation therapy in the management of patients with mesothelioma. Int J Radiat Oncol Biol Phys (1982) 1.01
Pleural mesothelioma. Cancer (1976) 0.99
Malignant mesothelioma. Current status and future prospects. Chest (1978) 0.98
[Radiotherapy of malignant pleural mesotheliomas. Apropos of 14 cases irradiated at high doses]. J Radiol Electrol Med Nucl (1973) 0.90
Pleural mesotheliomas--an analysis of 18 cases and review of the literature. Medicine (Baltimore) (1976) 0.89
The role of surgery in diffuse malignant mesothelioma of the pleura. Semin Oncol (1981) 0.88
High-dose methotrexate with citrovorum factor and vincristine in the treatment of malignant mesothelioma. Cancer (1982) 0.86
Transplantation of human malignant mesothelioma into nude mice. Cancer Res (1980) 0.86
The value of adriamycin in the treatment of diffuse malignant pleural mesothelioma. Cancer (1978) 0.86
Treatment of diffuse malignant mesothelioma: a review. Mt Sinai J Med (1978) 0.83
Diffuse, mixed malignant pleural mesothelioma. Ann Thorac Surg (1981) 0.82
Therapeutic approaches in malignant mesothelioma. Cancer Treat Rev (1977) 0.79
Shaping the dose distribution through a tumor model. Radiology (1969) 0.79
Chemotherapy for malignant mesothelioma; CAMEO. Am J Clin Oncol (1982) 0.78
A strategy to reduce cardiovascular disease by more than 80%. BMJ (2003) 19.05
The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ (1997) 8.05
On observing patterns of airflow obstruction in chronic asthma. Br J Dis Chest (1977) 6.54
Increasing incidence of tuberculosis in England and Wales: a study of the likely causes. BMJ (1995) 6.44
Quantifying the effect of folic acid. Lancet (2001) 4.86
Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med (1999) 4.81
Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax (1980) 3.70
Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nat Med (1995) 3.61
Identification of the cystic fibrosis gene. BMJ (1990) 3.28
Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis. Lancet (1990) 3.27
Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J (2000) 3.14
Q fever endocarditis treated with trimethoprim and sulphamethoxazole. Br Med J (1972) 3.06
By how much does dietary salt reduction lower blood pressure? II--Analysis of observational data within populations. BMJ (1991) 3.01
Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis. Lancet (1981) 2.87
Progressive airway obliteration in adults and its association with rheumatoid disease. Q J Med (1977) 2.83
Liver disease and bile duct abnormalities in adults with cystic fibrosis. Lancet (1989) 2.76
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol (2000) 2.73
Antibodies in some chronic fibrosing lung diseases. I. Non organ-specific autoantibodies. Clin Allergy (1971) 2.71
The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis. Am Rev Respir Dis (1983) 2.68
Circulating rheumatoid and antinuclear factors in asbestos workers. Br Med J (1970) 2.67
High-dose beclomethasone inhaler in the treatment of asthma. Lancet (1983) 2.58
Nocturnal asthma: a study in general practice. J R Coll Gen Pract (1989) 2.55
Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax (2001) 2.50
Cystic fibrosis in adolescents and adults. Thorax (1987) 2.47
Effects of long term inhaled high dose beclomethasone dipropionate on adrenal function. Thorax (1983) 2.35
Cryptogenic fibrosing alveolitis and lung cancer. Thorax (1980) 2.31
Bronchoalveolar lavage in pulmonary fibrosis: comparison of cells obtained with lung biopsy and clinical features. Thorax (1980) 2.28
Nocturnal and morning asthma. Relationship to plasma corticosteroids and response to cortisol infusion. Thorax (1975) 2.28
Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival. Thorax (1980) 2.27
Evaluation of the forced expiration technique as an adjunct to postural drainage in treatment of cystic fibrosis. Br Med J (1979) 2.15
A prognostic model for the prediction of survival in cystic fibrosis. Thorax (1997) 2.10
Meconium ileus equivalent in adults with cystic fibrosis of pancreas: a report of six cases. Br Med J (1976) 2.02
Management of pneumothorax in adults with cystic fibrosis. Thorax (1982) 1.99
Fibrosing alveolitis and chronic liver disease. Q J Med (1968) 1.91
The treatment and prognosis of medulloblastoma in children. A study of 82 verified cases. Am J Roentgenol Radium Ther Nucl Med (1969) 1.86
Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. Thorax (1980) 1.82
Association of HLA B8 with spontaneous resolution in sarcoidosis. Thorax (1981) 1.80
Autoantibodies against bactericidal/permeability-increasing protein in patients with cystic fibrosis. QJM (1996) 1.78
Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis. Am Rev Respir Dis (1981) 1.76
Malignant mesothelioma of the pleura: relation between histological type and clinical behaviour. Thorax (1982) 1.76
Management of lung cancer in South East Scotland. Thorax (1996) 1.75
Long term venous access using a totally implantable drug delivery system in patients with cystic fibrosis and bronchiectasis. Respir Med (1989) 1.75
Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis. Thorax (1989) 1.75
Improved survival at low lung function in cystic fibrosis: cohort study from 1990 to 2007. BMJ (2011) 1.74
Medium term treatment of stable stage cystic fibrosis with recombinant human DNase I. Thorax (1995) 1.72
Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med (1998) 1.72
Combined cryptogenic fibrosing alveolitis and emphysema: the value of high resolution computed tomography in assessment. Respir Med (1990) 1.71
alpha 1-antitrypsin phenotypes in fibrosing alveolitis and rheumatoid arthritis. Lancet (1977) 1.70
Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet (1999) 1.69
Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br Med J (Clin Res Ed) (1984) 1.68
Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis. Lancet (1987) 1.66
Demographic and social characteristics of adults with cystic fibrosis in the United Kingdom. BMJ (1993) 1.65
Quality of life in adults with cystic fibrosis. Thorax (1996) 1.64
Symptom control and quality of life in people with lung cancer: a randomised trial of two palliative radiotherapy fractionation schedules. Clin Oncol (R Coll Radiol) (2005) 1.61
Mycobacterial isolations in young adults with cystic fibrosis. Thorax (1984) 1.60
Host resistance and survival in carcinoma of breast: a study of 104 cases of medullary carcinoma in a series of 1,411 cases of breast cancer followed for 20 years. Br Med J (1970) 1.59
Pulmonary haemosiderosis and pulmonary haemorrhage. Br J Dis Chest (1981) 1.56
Methicillin-resistant Staphylococcus aureus: impact at a national cystic fibrosis centre. J Hosp Infect (1998) 1.55
Allergic bronchopulmonary aspergillosis in cystic fibrosis. A European epidemiological study. Epidemiologic Registry of Cystic Fibrosis. Eur Respir J (2000) 1.54
Hospital care for adults with cystic fibrosis: an overview and comparison between special cystic fibrosis clinics and general clinics using a patient questionnaire. Thorax (1994) 1.52
Interaction of corticosteroids and catecholamines in the treatment of asthma. Thorax (1975) 1.52
Aspergillus fumigatus and lung disease. Postgrad Med J (1979) 1.52
High prevalence of antinuclear antibodies in sandblasters' silicosis. Am Rev Respir Dis (1976) 1.51
Lymphocyte responses to phytohaemagglutinin in patients with asbestosis and pleural mesothelioma. Clin Exp Immunol (1978) 1.50
Chronic bronchial suppuration and inflammatory bowel disease. Q J Med (1981) 1.50
Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol (2001) 1.49
Cryptogenic fibrosing alveolitis: assessment by graded trephine lung biopsy histology compared with clinical, radiographic, and physiological features. Br J Dis Chest (1981) 1.49
Characterisation of the normal right ventricular pressure-volume relation by biplane angiography and simultaneous micromanometer pressure measurements. Br Heart J (1988) 1.48
Small-cell lung cancer after retinoblastoma. Lancet (1989) 1.48
Antibodies in some chronic fibrosing lung diseases. II. Immunofluorescent studies. Clin Allergy (1971) 1.47
Evidence in man of synergistic interaction between putative mediators of acute inflammation and asthma. Lancet (1982) 1.45
Circulating immune complexes in patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol (1979) 1.44
Long-term survival in patients with non-small cell lung cancer treated with palliative radiotherapy. Clin Oncol (R Coll Radiol) (2001) 1.43
Dynamics of reactive oxygen intermediate production in human glioma: n-6 essential fatty acid effects. Eur J Clin Invest (1999) 1.42
The British Thoracic Society. Thorax (1982) 1.42
Sweat tests to diagnose cystic fibrosis in adults. Br Med J (Clin Res Ed) (1983) 1.41
Structural features of interstitial lung disease in systemic sclerosis. Am Rev Respir Dis (1991) 1.41
Twice vs three-times daily antibiotics in the treatment of pulmonary exacerbations of cystic fibrosis. J Cyst Fibros (2011) 1.40
Intermediate-term results of heart-lung transplantation for cystic fibrosis. Lancet (1992) 1.40
Pulmonary disease in Behçet's syndrome. Q J Med (1986) 1.39
Circulating antinuclear antibody and rheumatoid factor in coal pneumoconiosis. Br Med J (1974) 1.39
Inhalation of antibiotics in cystic fibrosis. Eur Respir J (1995) 1.39
An audit of 3D treatment planning facilities and practice in the UK. Clin Oncol (R Coll Radiol) (1998) 1.39
A randomized double-blind crossover trial to investigate the efficacy of screening for adult hypothyroidism. J Med Screen (2010) 1.39
Prominent pericardial and myocardial lesions in the Churg-Strauss syndrome (allergic granulomatosis and angiitis). Thorax (1983) 1.39
The management of deeply infiltrating (T3) bladder carcinoma: controlled trial of radical radiotherapy versus preoperative radiotherapy and radical cystectomy (first report). Br J Urol (1976) 1.38
Computed tomography in adult obliterative bronchiolitis. Clin Radiol (1990) 1.38
Nedocromil sodium workshop. Respir Med (1989) 1.38
Increased sputum amino acid concentrations and auxotrophy of Pseudomonas aeruginosa in severe cystic fibrosis lung disease. Thorax (2000) 1.37
Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa. Thorax (1993) 1.37
Importance of viruses and Legionella pneumophila in respiratory exacerbations of young adults with cystic fibrosis. Thorax (1984) 1.36
Pain relief and quality of life following radiotherapy for bone metastases: a randomised trial of two fractionation schedules. Radiother Oncol (1997) 1.35
Linked marker haplotypes and the delta F508 mutation in adults with mild pulmonary disease and cystic fibrosis. Lancet (1990) 1.35
Helicobacter pylori infection and mortality from ischaemic heart disease: negative result from a large, prospective study. BMJ (1997) 1.34
Age has no impact on acute and late toxicity of curative thoracic radiotherapy. Radiother Oncol (1998) 1.34
Lack of inducible nitric oxide synthase in bronchial epithelium: a possible mechanism of susceptibility to infection in cystic fibrosis. J Pathol (1998) 1.34
Radiology of uncomplicated asthma. Thorax (1974) 1.33